Retinoblastoma: From genes to patient care

Autor: Bouchoucha, Y., Matet, A., Berger, A., Carcaboso, A.M., Gerrish, A., Moll, A., Jenkinson, H., Ketteler, P., Dorsman, J.C., Chantada, G., Beck-Popovic, M., Munier, F., Aerts, I., Doz, F., Golmard, L.

Publikováno v: In European Journal of Medical Genetics January 2023 66(1)

Anti-MAPK Targeted Therapy for Ameloblastoma: Case Report with a Systematic Review.

Autor: Raemy A; Department of Maxillofacial Surgery, Lausanne University Hospital, 1011 Lausanne, Switzerland., May L; Department of Maxillofacial Surgery, Lausanne University Hospital, 1011 Lausanne, Switzerland., Sala N; Institute of Pathology, Lausanne University Hospital, 1011 Lausanne, Switzerland., Diezi M; Department of Paediatric Oncology, Lausanne University Hospital, 1011 Lausanne, Switzerland., Beck-Popovic M; Department of Paediatric Oncology, Lausanne University Hospital, 1011 Lausanne, Switzerland., Broome M; Department of Maxillofacial Surgery, Lausanne University Hospital, 1011 Lausanne, Switzerland.

Publikováno v: Cancers [Cancers (Basel)] 2024 Jun 07; Vol. 16 (12). Date of Electronic Publication: 2024 Jun 07.

MR Imaging of Adverse Effects and Ocular Growth Decline after Selective Intra-Arterial Chemotherapy for Retinoblastoma.

Autor: de Bloeme CM; Cancer Center Amsterdam, Imaging and Biomarkers, 1081 HV Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., van Elst S; Cancer Center Amsterdam, Imaging and Biomarkers, 1081 HV Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Galluzzi P; Department of Neuroimaging Unit, Siena University Hospital, 53100 Siena, Italy., Jansen RW; Cancer Center Amsterdam, Imaging and Biomarkers, 1081 HV Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., de Haan J; Cancer Center Amsterdam, Imaging and Biomarkers, 1081 HV Amsterdam, The Netherlands., Göricke S; Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45147 Essen, Germany., Moll AC; Cancer Center Amsterdam, Imaging and Biomarkers, 1081 HV Amsterdam, The Netherlands.; Department of Ophthalmology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Bot JCJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Munier FL; Unit of Pediatric Ocular Oncology, Jules-Gonin Eye Hospital, University of Lausanne, 1015 Lausanne, Switzerland., Beck-Popovic M; Department of Pediatrics, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, 1011 Lausanne, Switzerland., Puccinelli F; Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, 1011 Lausanne, Switzerland., Aerts I; Pediatricic Department, Institut Curie, PSL Research University, 75005 Paris, France., Hadjistilianou T; Unit of Ophthalmology and Referral Center for Retinoblastoma, Department of Surgery, Policlinico 'Santa Maria alle Scotte', 53100 Siena, Italy., Sirin S; Department of Diagnostic Imaging, University Children's Hospital Zurich, University of Zurich, 8032 Zurich, Switzerland., Koob M; Department of Pediatrics, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, 1011 Lausanne, Switzerland., Brisse HJ; Imaging Department, Institut Curie, Paris University, 75005 Paris, France., Cardoen L; Imaging Department, Institut Curie, Paris University, 75005 Paris, France., Maeder P; Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, 1011 Lausanne, Switzerland., de Jong MC; Cancer Center Amsterdam, Imaging and Biomarkers, 1081 HV Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., de Graaf P; Cancer Center Amsterdam, Imaging and Biomarkers, 1081 HV Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2024 May 16; Vol. 16 (10). Date of Electronic Publication: 2024 May 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studies.

Autor: Belle FN; Childhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland., Schindera C; Childhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Division of Pediatric Oncology/Hematology, University Children's Hospital Basel, University of Basel, Basel, Switzerland., Ansari M; Division of Pediatric Oncology and Hematology, Department of Women, Child and Adolescent, University Geneva Hospitals, Cansearch Research platform for pediatric oncology and hematology, Faculty of Medicine, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland., Armstrong GT; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Tennessee, Memphis, USA., Beck-Popovic M; Pediatric Hematology-Oncology Unit, University Hospital (CHUV), Lausanne, Switzerland., Howell R; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Leisenring WM; Fred Hutchinson Cancer Center, Washington, Seattle, USA., Meacham LR; Aflac Cancer Center, Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia, USA., Rössler J; Division of Pediatric Hematology and Oncology, University Children's Hospital Bern, University of Bern, Bern, Switzerland., Spycher BD; Childhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Tonorezos E; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, USA., von der Weid NX; Division of Pediatric Oncology/Hematology, University Children's Hospital Basel, University of Basel, Basel, Switzerland., Yasui Y; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Tennessee, Memphis, USA., Oeffinger KC; Department of Medicine, Duke University and Duke Cancer Institute, Durham, North Carolina, USA., Kuehni CE; Childhood Cancer Research Group, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Division of Pediatric Hematology and Oncology, University Children's Hospital Bern, University of Bern, Bern, Switzerland.

Publikováno v: Cancer medicine [Cancer Med] 2023 Oct; Vol. 12 (20), pp. 20423-20436. Date of Electronic Publication: 2023 Oct 09.